Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;61(4):530-534.
doi: 10.1002/mus.26823. Epub 2020 Feb 7.

Evaluation of body composition as a potential biomarker in spinal muscular atrophy

Affiliations
Free article

Evaluation of body composition as a potential biomarker in spinal muscular atrophy

Giovanni Baranello et al. Muscle Nerve. 2020 Apr.
Free article

Abstract

Introduction: We aimed to investigate the correlation between body composition (BC) and spinal muscular atrophy (SMA)-specific motor function assessments.

Methods: Patients with SMA types I or II, aged 1 to 10 years, were recruited in this cross-sectional study. The protocol included anthropometric measurements, and dual-energy X-ray absoprtiometry to assess fat mass (FM), lean mass (LM), fat-free mass (FFM), FM and FFM indexes (FMI, FFMI), and motor function assessments (Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders scale for SMAI, and Hammersmith Functional Motor Scale-Expanded for SMAII).

Results: Eighty-eight children were included. All had a higher FM percentage than reference values. Motor function was moderately correlated with body mass index (BMI), FFMI, and LMI in SMAI, and weakly correlated with FFMI, LMI, and LM:FM ratio in SMAII.

Discussion: BC shows promise as a potential biomarker for SMA, but further studies are needed.

Keywords: Hammersmith Functional Motor Scale―Expanded; The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders; body composition; fat-free mass; spinal muscular atrophy.

PubMed Disclaimer

References

REFERENCES

    1. Finkel RS, Mercuri E, Darras BT, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377:1723-1732.
    1. Mercuri E, Darras BT, Chiriboga CA, et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018;378:625-635.
    1. Krosschell KJ, Bosch M, Nelson L, et al. Motor function test reliability during the NeuroNEXT spinal muscular atrophy infant biomarker study. J Neuromuscul Dis. 2018;5:509-521.
    1. Fosbol MO, Zerahn B. Contemporary methods of body composition measurement. Clin Physiol Funct Imaging. 2015;35:81-97.
    1. Skalsky AJ, Han JJ, Abresch RT, McDonald CM. Regional and whole-body dual-energy X-ray absorptiometry to guide treatment and monitor disease progression in neuromuscular disease. Phys Med Rehabil Clin N Am. 2012;23:67-73.

Publication types